We and others have demonstrated that levels of BDNF mRNA and protein are significantly decreased in the AD brain [43,44,45,46] and have suggested that modulation of endogenous BDNF levels may represent a therapeutic avenue for AD [47,48]. Here, BDNF is linked to Alzheimer disease.